Dow Up1.06% Nasdaq Up0.99%

More On ACEL

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Tamir Biotechnology, Inc. (ACEL)

-Other OTC
0.05 0.00(0.00%) Jun 19, 12:26PM EDT
|Pre-Market : NaN
CompetitorsGet Competitors for:
Direct Competitor Comparison 
ACELLLYIMGNMRKIndustry
Market Cap:N/A68.55B789.49M162.49BN/A
Employees:N/A37,92530777,300N/A
Qtrly Rev Growth (yoy):N/A-0.170.50-0.01N/A
Revenue (ttm): N/A21.20B59.90M43.55BN/A
Gross Margin (ttm):N/A0.76-0.790.63N/A
EBITDA (ttm):N/A5.69B-66.93M15.95BN/A
Operating Margin (ttm): N/A0.20-1.190.22N/A
Net Income (ttm):N/A3.39B-71.36M5.61BN/A
EPS (ttm):-0.053.15-0.841.90N/A
P/E (ttm):N/A20.31N/A29.68N/A
PEG (5 yr expected):N/A58.80N/A2.92N/A
P/S (ttm):N/A3.2712.913.68N/A
 
LLY = Eli Lilly and Company
IMGN = ImmunoGen, Inc.
MRK = Merck & Co. Inc.

 
News on Direct Competitors 

Currency in USD.